ArticleBritish journal of clinical pharmacology2026

Long-term impact of Elexacaftor/Tezacaftor/ivacaftor on pulmonary, nutritional and metabolic outcomes in homozygous F508del cystic fibrosis patients: A real-world cohort study.

Nicola Perrotta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.